Patent · US Active

Biotechnological production of chondroitin

US8771992B2 · kind B2 · utility

1Cited by

0References

10Claims

0Family size

Assignee

GNOSIS SPA · IT

Inventors

Antonio Trilli · Lugano, CH
Immacolata Busiello · Giubiasco, CH
Simona Daly · Monza, IT
Francesca Bagatin · Rovello Porro, IT

Key dates

Filing date	Nov 13, 2013
Grant date	Jul 8, 2014
Priority date	—
Expiry date	Nov 13, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y204/01099
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Chondroitin is produced by culturing a recombinant microorganism which is obtained by inactivation of a gene encoding an enzyme responsible for addition of fructose residues to the linear chondroitin polysaccharide in a microorganism producing a fructosylated derivative of chondroitin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.